TheStreet Lowers Livent (NYSE:LTHM) to D+

Livent (NYSE:LTHM) was downgraded by analysts at TheStreet from a “c-” rating to a “d+” rating in a report issued on Friday, TheStreetRatingsTable reports.

LTHM has been the subject of a number of other research reports. Raymond James lowered shares of Livent from a “strong-buy” rating to an “outperform” rating and lifted their target price for the stock from $18.00 to $24.00 in a report on Friday, January 8th. Smith Barney Citigroup lowered shares of Livent from a “buy” rating to a “neutral” rating in a report on Wednesday, January 6th. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell lowered shares of Livent from a “buy” rating to a “neutral” rating and lifted their target price for the stock from $16.50 to $22.00 in a report on Wednesday, January 6th. Loop Capital boosted their price target on shares of Livent from $13.00 to $21.00 and gave the company a “buy” rating in a report on Wednesday, December 9th. They noted that the move was a valuation call. Finally, Evercore ISI boosted their price objective on shares of Livent from $10.00 to $20.00 in a research report on Tuesday, January 5th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the stock. Livent presently has a consensus rating of “Hold” and an average price target of $15.30.

Shares of Livent stock opened at $20.35 on Friday. The company has a debt-to-equity ratio of 0.40, a current ratio of 3.24 and a quick ratio of 1.78. The firm has a market cap of $2.98 billion, a P/E ratio of -226.11, a P/E/G ratio of 5.25 and a beta of 2.24. The firm has a 50 day simple moving average of $21.00 and a 200 day simple moving average of $14.17. Livent has a fifty-two week low of $3.95 and a fifty-two week high of $23.99.

Livent (NYSE:LTHM) last issued its quarterly earnings results on Wednesday, February 17th. The company reported ($0.02) earnings per share for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.03). Livent had a negative net margin of 4.96% and a positive return on equity of 0.59%. On average, sell-side analysts expect that Livent will post -0.03 EPS for the current year.

In other Livent news, CEO Paul W. Graves sold 4,991 shares of the business’s stock in a transaction dated Friday, January 8th. The shares were sold at an average price of $22.09, for a total transaction of $110,251.19. Following the sale, the chief executive officer now directly owns 241,957 shares of the company’s stock, valued at approximately $5,344,830.13. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.98% of the company’s stock.

Hedge funds have recently modified their holdings of the company. Victory Capital Management Inc. grew its stake in Livent by 480.2% in the 3rd quarter. Victory Capital Management Inc. now owns 2,491,749 shares of the company’s stock valued at $22,351,000 after buying an additional 2,062,264 shares during the last quarter. Axel Capital Management LLC grew its stake in Livent by 2,007.2% in the 4th quarter. Axel Capital Management LLC now owns 1,685,749 shares of the company’s stock valued at $31,759,000 after buying an additional 1,605,749 shares during the last quarter. Handelsbanken Fonder AB grew its stake in Livent by 8,582.2% in the 4th quarter. Handelsbanken Fonder AB now owns 1,623,565 shares of the company’s stock valued at $30,588,000 after buying an additional 1,604,865 shares during the last quarter. BlackRock Inc. grew its stake in Livent by 5.9% in the 4th quarter. BlackRock Inc. now owns 24,091,663 shares of the company’s stock valued at $453,886,000 after buying an additional 1,340,228 shares during the last quarter. Finally, Morgan Stanley grew its stake in Livent by 172.9% in the 4th quarter. Morgan Stanley now owns 1,646,778 shares of the company’s stock valued at $31,024,000 after buying an additional 1,043,360 shares during the last quarter. 99.98% of the stock is currently owned by institutional investors.

About Livent

Livent Corporation manufactures and sells performance lithium based batteries, specialty polymer, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries.

See Also: Why Invest in High-Yield Dividend Stocks?

Analyst Recommendations for Livent (NYSE:LTHM)

Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.